Financial Appendix. Terms describing calculations and reporting of Operating Profits (Losses) are set forth in the Financial Appendix. The Financial Appendix is applicable to revenues and expenses by a Party in the United States. For revenues and expenses by a Sublicensee, the definitions may need to be modified to comply with changes to GAAP or to comply with ex-U.S. financial accounting standards. Any such modification, however, will be consistent with the agreed Cost Sharing Ratio and with the material concepts in the existing Financial Appendix.
Financial Appendix. For purposes of this Exhibit only, the consolidated accounting of operations for the collaboration in the Shared Territory shall be referred to as the “Collaboration”. The Collaboration is not a legal entity, or a partnership within the meaning of any tax laws, and has been defined for identification purposes only. This Financial Appendix addresses the financial planning, accounting policies and procedures to be followed in determining Profits and Losses, and related sharing of revenue and expenses, in the Shared Territory between Roche Nutley and Prothena US (for purposes of this Exhibit 1.35 only, the “Collaboration Parties”). Terms not defined in this Exhibit shall have the meanings set forth in Article 1 of the body of this Agreement. This Exhibit sets forth the principles for reporting actual results and budgeted plans of the combined operations by the Collaboration Parties in the Shared Territory, the frequency of reporting, the use of a single functional currency for reporting, and the methods of determining payments to the Collaboration Parties and auditing of accounts.
Financial Appendix. This Exhibit E sets forth the principles for capturing, reporting and consolidating Development Costs, Commercialization Costs, and Profit sharing. Roche shall be responsible for all other costs with respect to Licensed Product(s). For such purpose, this Exhibit E sets forth the principles for reporting actual results and budgeted plans in the United States, the frequency of reporting, the use of a single “Functional Currency” (as defined under the heading “Foreign Exchange” below) and the methods of determining payments to the Parties, auditing of accounts and other matters.
Financial Appendix. The agreed Milestone Payment Plans for phases C/D and support to phase E1 are indicative and will be finally consolidated prior to the start of phase C/D and phase E1 respectively
Financial Appendix. 4 1.47 Finished Product............................................4 1.48 First Commercial Sale........................................4 1.49 First Offer Termination Date.................................4 1.50 Fully Burdened Manufacturing Cost............................4 1.51 GAAP.........................................................5 1.52 General and Administrative Costs.............................5 1.53
Financial Appendix. The term “
Financial Appendix. This Appendix (“Financial Appendix”) to the Collaboration, Option and License Agreement between F. Hoffmann-La Roche Ltd, with an office and place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (“Roche Basel”) and Hoffmann-La Roche Inc., with an office and place of business at 150 Clove Road, Suite 8, Little Falls, New Jersey 07424, U.S.A. (“Roche US”; Roche Basel and Roche US together referred to as “Roche”), on the one hand, and Vividion, Inc., with an office and place of business at 5820 Nancy Ridge Drive, San Diego, CA 92121, U.S.A. (“Vividion”), on the other hand, effective as of April 3, 2020 (the “Agreement”) addresses certain financial definitions and related principles of reporting and reconciliation to be followed in determining on a Vividion PoC Program-by-Vividion PoC Program basis with respect to each Vividion PoC Program and on a Shared Product-by-Shared-Shared Product basis (but not for any Compounds or Products, under Roche Programs, Optioned Roche Programs), and for the purposes of this Appendix and the Agreement only, the sharing of (a) costs pertaining to the Development of Compounds and Products under Vividion PoC Programs and/or Shared Products for the Territory, as applicable, and (b) Shared Profits and Losses for Shared Products in the US, each (a) and (b) as set forth in the Agreement and this Appendix 1. Terms not defined in this Financial Appendix shall have the meanings set forth in the body of the Agreement to which this Financial Appendix is attached. For each Vividion PoC Program or Shared Product and on a Vividion PoC Program-by-Vividion PoC Program or Shared Product-by-Shared Product basis, the following processes and definitions shall be utilized to calculate, and reimburse or share, as applicable, such Allowable Expense and Shared Profits and Losses (for Shared Products only) between the Parties.
Financial Appendix. This document is necessary : - for a period of vocational maritime workplace training exceeding two months in a single host organisation, - for a placement under two months, if required by the educational establishment for better management of organisational costs of workplace training periods. The present form has to be filled and sent with the signed agreement. Class : Qualification worked for or towards :
Financial Appendix. Student’s first and last names: Class:
Financial Appendix. This provides the definitions of certain financial terms applicable to the Parties for purposes of the Agreement; provided, however, that the definition of "Fully Burdened Manufacturing Costs" shall apply to ERS or the Company to the extent it manufactures any Product (or component thereof) under the Agreement and the definition of "Development Costs" shall apply to the development work of the Parties under the Agreement. All capitalized terms used herein without definition shall have the meanings ascribed thereto in the Agreement, unless otherwise expressly provided herein. References in this Exhibit 1.46
